References
- King H, Aubert RE, Herman WH. Global burden of diabetes, 1995--2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431
- Chowdhury TA, Lasker SS. Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes. QJM. 2002;95:241–246
- United States Renal Data System. USRDS 2007 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, US Department of Health and Human Services; 2007
- National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics, 2007. Bethesda, MD: National Institutes of Health, US Department of Health and Human Services; 2008
- Ramachandran A. Epidemiology of diabetes in India—three decades of research. J Assoc Physicians India. 2005;53:34–38
- Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787
- Geneau R, Stuckler D, Stachenko S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet. 2010;376:1689–1698
- Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350
- Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2011;54:300–307
- Kramer H, Molitch ME. Screening for kidney disease in adults with diabetes. Diabetes Care. 2005;28:1813–1816
- Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med. 2003;139:137–147
- Janssen I, Heymsfield SB, Allison DB, et al. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous and visceral fat. Am J Clin Nutr. 2002;75:683–688
- The DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases? Diabetes Care. 2003;26:688–696
- Tushuizen ME, Diamant M, Heine RJ. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes. Postgrad Med. 2005;81:1–6
- WHO/IASO/IOTF. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications Australia Pty Limited on behalf of the Steering Committee (WHO Western Pacific region), Australia: Melbourne; 2000
- Singh AK, Pandey A, Tewari M, et al. Obesity augmented breast cancer risk: a potential risk factor for Indian women. J Surg Oncol. 2011;103(3):217–222
- Cockcroft DW, Gault HM. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
- DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight are known. Ann Intern Med. 1916;17:863–871
- Ritz E, Rychlík I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34:795–808
- Stel VS, Tomson C, Ansell D, et al. Level of renal function in patients starting dialysis: an ERA-EDTA Registry Study. Nephrol Dial Transplant. 2010;25:3315–3325
- Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51:1908–1919
- Lin CH, Yang WC, Tsai ST, Tung TH, Chou P. A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract. 2007;75:306–312
- Lu B, Song X, Dong X, et al. High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diabetes Complications. 2008;22:96–103
- Ishikawa T, Hashimoto J, Morito RH, et al. Association of microalbuminuria with brachial-ankle pulse wave velocity: the Ohasama Study. Am J Hypertens. 2008;21:413–418
- Palmas W, Pickering T, Teresi J, et al. Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens (Greenwich). 2008;10:12–20
- Palmas W, Moran A, Pickering T, et al. Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension. 2006;48:301–308
- Tanaka M, Babazono T, Takeda M, Iwamoto Y. Pulse pressure and chronic kidney disease in patients with type 2 diabetes. Hypertens Res. 2006;29:345–352
- Knudsen ST, Andersen NH, Mogensen CE. Ambulatory pulse pressure and progression of albuminuria in type 2 diabetes: evidence provided, new questions emerge. Hypertension. 2006;48:207–208
- Arulkumaran N, Diwakar R, Tahir Z, Mohamed M, Kaski JC, Banerjee D. Pulse pressure and progression of chronic kidney disease. J Nephrol. 2010;23:189–193
- Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30:753–759
- Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004;164:2147–2155
- Ceriello A. Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia. Am Heart J. 2004;147:803–807
- Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabet Med. 2008;25:1151–1156
- Kebapci N, Uslu S, Ozcelik E. Metabolic syndrome is a risk factor for the development of chronic renal disease. Ren Fail. 2013;35(4):460–465